Trademark Search in Canada

INFILBRAY

View On IC.GC.CA

REGISTERED

on 8 Mar 2023

Last Applicant/ Owned by

GENZYME CORPORATION

50 Binney StreetCambridge, MA 02142

Serial Number

2085043 filed on 17^th Feb 2021

Registration Number

TMA1170070 registered on 8^th Mar 2023

Registration expiry Date

8^th Mar 2033

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

M5H3Y2

INFILBRAY

Trademark usage description

pharmaceutical preparations for the prevention and treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of autosomal Read More

Classification Information

Class [005]
Pharmaceutical preparations for the prevention and treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of autosomal dominant polycystic kidney disease;

Classification kind code

Mark Details

Serial Number

2085043

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 8^th Mar 2023	Registration Pending
Submitted for opposition 55 on 8^th Mar 2023	Registered
Submitted for opposition 42 on 21^st Dec 2022	Advertised
Submitted for opposition 26 on 28^th Nov 2022	Approved
Submitted for opposition 27 on 28^th Nov 2022	Approval Notice Sent
Submitted for opposition 22 on 22^nd Nov 2022	Search Recorded
Submitted for opposition 287 on 28^th Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 17^th Feb 2021	Filed
Submitted for opposition 1 on 17^th Feb 2021	Created
Submitted for opposition 31 on 17^th Feb 2021	Formalized

INFILBRAY

Classification Information

Class [005]Pharmaceutical preparations for the prevention and treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of autosomal dominant polycystic kidney disease;

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparations for the prevention and treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of autosomal dominant polycystic kidney disease;